Li, H., Yang, Z., & Guo, Q. (2021). Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: Limitations and prospects: a systematic review. BMC.
Cita Chicago Style (17a ed.)Li, Hong-Bo, Zi-Han Yang, y Qing-Qu Guo. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Limitations and Prospects: A Systematic Review. BMC, 2021.
Cita MLA (8a ed.)Li, Hong-Bo, et al. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Limitations and Prospects: A Systematic Review. BMC, 2021.
Precaución: Estas citas no son 100% exactas.